Swiss Pharma Nigeria Limited

Swiss Pharma Nigeria Limited (Swipha), a subsidiary of Servier, a French Pharmaceutical Company, is making strides in the Nigerian pharmaceutical industry. With a focus on providing high-quality and affordable medicines for patients, Swipha has positioned itself as a key player in the sector. Founded in 1976, the company has set ambitious goals for its future, aiming to lead the premium generics Pharma segment in Nigeria, make its mark as one of the top 10 in the Nigerian Pharma Industry, and become a hub for WHO pre-qualified products in Africa. Swipha's alignment with Servier, a company employing over 20,000 individuals, with nearly 3,000 dedicated to Research and Development, underscores its commitment to innovation and excellence. While specific investment details are not currently available, the company's dedication to its mission and vision signals its potential for growth and impact in the pharmaceutical industry. With its base in Nigeria, Swipha has positioned itself to tap into the growing demand for pharmaceutical products in the African market. As the company continues to expand its reach and enhance its product offerings, it presents an intriguing opportunity for potential investors seeking to engage with a dynamic player in the pharmaceutical space.